|
|
|
|
|
|
|
|
|
|
Researchers Identify Genetic Mutation That May Alter Patients' Response To Cancer Therapeutics: "Researchers from Eli Lilly & Company and the Phoenix-based Translational Genomics Research Institute (TGen) today announced finding a novel recurring mutation of the gene AKT1 in breast, colorectal and ovarian cancers. "
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.